Kristina Jiali Fusella is a purpose-driven, transformational commercial leader with deep expertise in market access, brand marketing, commercial strategy, sales planning, analytics, and insights across the pharmaceutical sector. Leveraging a courageous and team-focused leadership approach, she relentlessly pursues excellence while championing innovation and continuous improvement. Comfortable in the face of uncertainty, Kristina translates complex analytics into actionable strategies while navigating ambiguity to unearth growth opportunities. As an influential business leader and catalyst for change, Kristina disrupts the status quo and aligns teams toward a unified vision.
Since joining Novo Nordisk, Inc., in 2015, Kristina has advanced through multiple key positions and now holds the role of Senior Director of Strategic Planning and Executive Support for Strategy and Rare Disease. As a pivotal member of the senior leadership team, she serves as the senior vice president's chief of staff, ensuring the commercial unit's seamless functioning while providing strategic insights that help build a sustainable future beyond the core business.
In her current role, Kristina spearheaded the strategic planning process for the rare disease and future business group, translating a long-term strategy into actionable yearly plans across multiple therapy areas. As a crucial advisor to the senior vice president and leadership team, she delivered valuable insights and identified synergies across various departments. She also created a collaborative information network, cultivating robust relationships among chiefs of staff across all of the executive teams.
Perhaps more of us would find greater joy and fulfillment at work, if we embraced the idea of being a beginner and starting anew. The most fulfilling path in the 21st century isn’t necessarily a straight line.